Changing trends in thyroid practice: Understanding nodular thyroid disease

Endocrine Practice

Volumn 10, Issue 1, 2004, Pages 31-39

  Gharib, Hossein ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT;

HUMAN; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; PREVALENCE; PROFESSIONAL PRACTICE; REVIEW; THYROID FUNCTION TEST; THYROID GLAND; THYROID NODULE;

ANTITHYROID AGENTS; BIOPSY, FINE-NEEDLE; HUMANS; PREVALENCE; PROFESSIONAL PRACTICE; THYROID FUNCTION TESTS; THYROID GLAND; THYROID NODULE;

EID: 3242879158     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.10.1.31     Document Type: Review

References (49)

1. Gross J, Pitt-Rivers R. The identification of 3:5:3′-l- triiodothyronine in human plasma. Lancet. 1952;1:439-441.
2. Ekins RP. The estimation of thyroxine in human plasma by an electrophoretic technique. Clin Chim Acta. 1960;5: 453-459.
3. Murphy BP. The determination of thyroxine by competitive protein-binding analysis employing an anion-exchange resin and radiothyroxine. J Lab Clin Med. 1965;66:161-167.
4. Arango G, Mayberry WE, Hockert TJ, Elveback LR. Total and free human serum thyroxine in normal and abnormal thyroid states. Mayo Clin Proc. 1968;43:503-516.
5. Condliffe PG. Purification of human thyrotrophin. Endocrinology. 1963;72:893-896.
6. Odell WD, Wilber JF, Utiger RD. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Hormone Res. 1967;23:47-85.
7. Mayberry WE, Gharib H, Bilstad JM, Sizemore GW. Radioimmunoassay for human thyrotrophin: clinical value in patients with normal and abnormal thyroid function. Ann Intern Med. 1971;74:471-480.
8. Hershman JM, Pittman JA Jr. Utility of the radioimmunoassay of serum thyrotrophin in man. Ann Intern Med. 1971;74:481-490.
9. Sterling K, Refetoff S, Selenkow HA. T3 thyrotoxicosis: thyrotoxicosis due to elevated serum triiodothyronine levels. JAMA. 1970;213:571-575.
10. Sterling K, Bellabarba D, Newman ES, Brenner MA. Determination of triiodothyronine concentration in human serum. J Clin Invest. 1969;48:1150-1158.
11. Mayo CH, Plummer HS. The Thyroid Gland. St. Louis, MO: CV Mosby Co, 1926.
12. Gharib H, Ryan RJ, Mayberry WE, Hockert T. Radioimmunoassay for triiodothyronine (T3): I. Affinity and specificity of the antibody for T3. J Clin Endocrinol Metab. 1971;33:509-516.
13. Gharib H, Ryan RJ, Mayberry WE. Triiodothyronine (T3) radioimmunoassay: a critical evaluation. Mayo Clin Proc. 1972;47:934-937.
14. Gharib H, Wahner HW, McConahey WM. Serum levels of thyroid hormones in Hashimoto's thyroiditis. Mayo Clin Proc. 1972;47:175-179.
15. Rall JE, Sterling K, Gharib H, Mayberry WE. Thyroid hormone analyses. In: Berson SA, ed. Methods in Investigative and Diagnostic Endocrinology. Vol 1. Amsterdam: North-Holland Publishing Company, 1972: 204-240.
16. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968;69:537-540.
17. Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab. 1955;15:1270-1280.
18. Horlocker TT, Hay JE, James EM, Reading CC, Charboneau JW. Prevalence of incidental nodular thyroid disease detected during high-resolution parathyroid ultrasonography. In: Medeirosneto G, Gaitan E, eds. Frontiers in Thyroidology. Vol 2. New York, NY: Plenum Medical Book Company, 1986: 1309-1312.
19. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328:553-559.
20. Rojeski MT, Gharib H. Nodular thyroid disease: evaluation and management. N Engl J Med. 1985;313:428-436.
21. DeGroot LJ. Most solitary thyroid nodules should be removed. In: Ingelfinger FJ, Ebert RV, Finland M, Relman AS, eds. Controversies in Internal Medicine. 2nd ed. Philadelphia, PA: WB Saunders, 1974: 421-427.
22. Greer MA. Thyroid nodules: surgery is usually not necessary. In: Ingelfinger FJ, Ebert RV, Finland M, Relman AS, eds. Controversies in Internal Medicine. 2nd ed. Philadelphia, PA: WB Saunders, 1974: 428-434.
23. Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration cytology of the thyroid, 1980-1986. Acta Cytol. 1987;31:587-590.
24. Gharib H, Goellner JR. Evaluation of nodular thyroid disease. Endocrinol Metab Clin North Am. 1988;17:511-526.
25. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc. 1994;69:44-49.
26. Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid: a 12-year experience with 11,000 biopsies. Clin Lab Med. 1993;13:699-709.
27. Gharib H, Goellner JR, Zinsmeister AR, Grant CS, van Heerden JA. Fine-needle aspiration biopsy of the thyroid: the problem of suspicious cytologic findings. Ann Intern Med. 1984;101:25-28.
28. Miller JM, Hamburger JI, Kini SR. The needle biopsy diagnosis of papillary thyroid carcinoma. Cancer. 1981;48:989-993.
29. Reeve TS, Delbridge L, Sloan D, Crummer P. The impact of fine-needle aspiration biopsy on surgery for single thyroid nodules. Med J Aust. 1986;145:308-311.
30. Baskin HJ, Guarda LA. Influence of needle biopsy on management of thyroid nodules: reasons to expand its use. South Med J. 1987;80:702-705.
31. Caplan RH, Strutt PJ, Kisken WA, Wester SM. Fine needle aspiration biopsy of thyroid nodules. Wis Med J. 1991;90:285-288.
32. Garcia-Mayor RV, Perez Mendez LF, Paramo C, et al. Fine-needle aspiration biopsy of thyroid nodules: impact on clinical practice. J Endocrinol Invest. 1997;20:482-487.
33. Hadi M, Gharib H, Goellner JR, van Heerden JA. Has fine-needle aspiration biopsy changed thyroid practice? Endocr Pract. 1997;3:9-13.
34. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118:282-289.
35. Hamberger B, Gharib H, Melton LJ III, Goellner JR, Zinsmeister AR. Fine-needle aspiration biopsy of thyroid nodules: impact on thyroid practice and cost of care. Am J Med. 1982;73:381-384.
36. Bennedbaek FN, Hegedus L. Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab. 2000;85:2493-2498.
37. Burguera B, Gharib H. Thyroid incidentalomas: prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am. 2000;29:187-203.
38. Tan GH, Gharib H, Reading CC. Solitary thyroid nodule: comparison between palpation and ultrasonography. Arch Intern Med. 1995;155:2418-2423.
39. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993;328:1237-1243.
40. Gharib H. Management of thyroid nodules: another look. Thyroid Today. 1997;1:1-11.
41. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am. 1997;26:777-800.
42. Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med. 1998;128:386-394.
43. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study. N Engl J Med. 1987;317:70-75.
44. Reverter JL, Lucas A, Salinas I, Audi L, Foz M, Sanmarti A. Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf). 1992;36: 25-28.
45. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med. 1995;122:1-8.
46. Zelmanovitz F, Genro S, Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab. 1998;83:3881-3885.
47. Csako G, Byrd D, Wesley RA, et al. Assessing the effects of thyroid suppression on benign solitary thyroid nodules: a model for using quantitative research synthesis. Medicine (Baltimore). 2000;79:9-26.
48. Derwahl M, Broecker M, Kraiem Z. Clinical review 101: thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab. 1999;84:829-834.
49. Krohn K, Paschke R. Clinical review 133: progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab. 2001;86:3336-3345.